CIN: Ablative Therapies



Fig. 14.1
Cryotherapy unit



A418771_1_En_14_Fig2_HTML.gif


Fig. 14.2
Cryotherapy probes


The cryotherapy unit consists of a cryotherapy gun attached to a flexible gas conveying tube, a pressure gauge showing the cylinder gas pressure, an outlet silencer, a gas trigger to allow the release of gas from reservoir to cryoprobe at high pressure and a cryoprobe.

Cryoprobes are of two types; flat tip and a probe with 2 mm endocervical extension. Silver and copper are the best materials to use in probe tips because high conductivity produces both a better freezing effect and a more effective local cryonecrosis [6]. The size and shape of the probe affect the depth of cryonecrosis [7].

The 19 and 25 mm mini-cone tips are recommended for the required depth of cryonecrosis.


14.3.4.1 Gas Cylinder


Gases selected for cryotherapy should have their freezing point below the cryogenic range from −20 to −30 °C needed for tissue destruction. Nitrous oxide (N2O) and carbon dioxide are used for cryotherapy as these gases provide excellent thermal transfer when circulating in the probe tip (Fig. 14.3) [8, 9].

A418771_1_En_14_Fig3_HTML.gif


Fig. 14.3
Gas cylinder

Nitrous oxide produces lower temperatures to a greater depth than carbon dioxide [10]. The comparison of depth of tissue destruction is shown in Table 14.1.


Table 14.1
Depth of tissue destruction




















Depth of destruction

Gas

Temperature

3 mm

Carbon dioxide

−68 °C

5 mm

Nitrous oxide

−89 °C



14.3.5 Eligibility Criteria for Cryotherapy






  • Lesion should be on the ectocervix and visible in its entire extent. No extension of lesion is noted in the endocervical canal or vagina.


  • The lesion can be adequately covered by the cryotherapy probe and it should not extend 2 mm beyond the tip of the cryotherapy probe.


  • The CIN lesion should be confirmed by colposcopy or biopsy.


14.3.6 Exclusion Criteria





  1. 1.


    Pregnancy

    Cryotherapy is not to be carried out in pregnant women as the risk of pregnancy loss is greater when it is performed during pregnancy.

    During pregnancy, a follow-up of CIN lesions with colposcopy in each trimester is done but therapy is delayed up to 12 weeks postpartum [11].

     

  2. 2.


    Invasive carcinoma

    Cryotherapy should not be done before invasion is ruled out. There should not be suspicion of glandular dysplasia.

     

  3. 3.


    Pelvic inflammatory disease (PID)

    It is advisable to delay the cryotherapy until the infection has been treated and resolved completely. The risk of postoperative infection after cryotherapy is minimal but can be increased if the procedure is carried out in women with pelvic inflammatory disease, sexually transmitted cervicitis like chlamydia or gonorrhea, vaginal trichomoniasis, and bacterial vaginosis.

     

  4. 4.


    Marked atrophic changes of the cervix

    In old women, if there is a marked atrophy due to estrogen deficiency, the staining of the outer margin of the lesion is indistinct. In such conditions, cryotherapy may be carried out after a course of topical estrogen treatment and colposcopic reassessment.

     

  5. 5.


    Menstruation

    Cryotherapy is not to be done during menstruation.

     


14.3.7 Technique of Cryotherapy


Before proceeding to cryotherapy, the health provider must confirm that the patient is eligible for the therapy as per the eligibility criteria. An informed consent is taken. The clinician should explain the procedure to the patient and reassure her. The procedure is carried out under colposcopic guidance without anesthesia (Fig. 14.4).

A418771_1_En_14_Fig4_HTML.gif


Fig. 14.4
Instrument trolley for cryotherapy

Woman should be placed in a dorsal lithotomy position and Cusco’s speculum is inserted to expose the cervix. The cryoprobe surface is wiped with saline or coated with water-soluble lubricating jelly to provide good contact and firm application of the cryoprobe tip to the cervix and an optimal lowering of the tissue temperature. While applying cryoprobe, care is taken so that the vaginal walls are not in contact with the cryoprobe. No anesthesia is required except in very anxious patients who may be given NSAID 30 min prior to the procedure.

The probe should cover the lesion completely. The gas trigger in the cryogun is released and the gas escapes with a hissing noise. The gas circulating through the cryoprobe withdraws heat from the cervix till the freezing temperature is reached. As freezing progresses, ice forms on the cervix and on the cryoprobe. The rapidity of the ice-ball formation and efficacy of the procedure depend on:



  • Adequate pressure of gas in the tank or reservoir


  • Proper and firm application of the probe on the cervix


  • Cryogenic gas used [9] (Fig. 14.5)

    A418771_1_En_14_Fig5_HTML.gif


    Fig. 14.5
    Needle in pressure gauge should be in the green region

Nitrous oxide based cryotherapy achieves a temperature of about −89 °C and carbon dioxide based system achieves −68 °C at the core of the tissue that is at the center of the ice ball. The temperature at the edge of the frozen tissue may be around −20 °C.The minimum temperature of the probe tip for effective tissue freezing should be −60 °C. An adequate freezing is achieved when the margin of the ice ball extends 4–5 mm past the outer edge of the cryotip; this will ensure that cryonecrosis occurs down to at least 5 mm depth [9].

The two methods of cryotherapy are as follows:


  1. 1.


    Single freeze: In this method, cryogenic gas is applied continuously.

     

  2. 2.


    Double freeze: It consists of two sequential “freeze–thaw” cycles; each cycle consists of 3 min of freezing followed by 5 min of thawing (3 min freeze–5 min thaw–3 min freeze–5 min thaw).

     

The double freeze technique produces more tissue destruction than the single freeze cycle [6, 12].

When thawing is completed, the ice on the cryoprobe is totally cleared and then the probe is removed by gently rotating on the cervix. After the procedure, the cervix is examined for any bleeding (Fig. 14.6).

A418771_1_En_14_Fig6_HTML.gif


Fig. 14.6
Cryotherapy in progress (a, b)



  1. (a)


    Cryoprobe in firm contact with the cervix, process of freezing in progress

     

  2. (b)


    Ice formation at the center and at the edge of the probe tip

     

  3. (c)


    Appearance of the cervix immediately after cryotherapy (Fig. 14.7)

    A418771_1_En_14_Fig7_HTML.jpg


    Fig. 14.7
    Cervix immediately after cryotherapy

     


14.3.8 Cleaning of Cryoprobe and Cryogun


The cryotip is washed with clean water until visibly clean. The high-level disinfection (HLD) of cryotip is done by boiling in water for 20 min or soaking the cryotip in chemical disinfectant for 20 min and then rinsed with water. It is critical that the hollow part of the cryotip is completely dry before it is used for the next case; otherwise the water would freeze and the probe could crack.


14.3.9 Adverse Effects






  • Uterine cramping may occur during or shortly after treatment.


  • Rarely vasovagal syncope may occur during the procedure in anxious patients.


  • Profuse watery vaginal discharge is seen for 2–4 weeks after the therapy. So after cryotherapy, the vagina should not be packed to allow secretions to escape.


14.3.10 Long-Term Complications (Table 14.2)


Aug 25, 2017 | Posted by in GYNECOLOGY | Comments Off on CIN: Ablative Therapies

Full access? Get Clinical Tree

Get Clinical Tree app for offline access